Effects of andrographolide on NF-κB signaling pathway in human lung adenocarcinoma A549 cells

任丹虹,方堃,应可净

DOI: https://doi.org/10.3867/j.issn.1000-3002.2010.02.005

2010-01-01

Abstract:OBJECTIVE To investigate the effect of andrographolide (Andro) on the nuclear factor-kappa B (NF-κB) signaling pathway in human lung adenocarcinoma cell line A549 and possible mechanisms. METHODS A549 cells were treated with Andro 1.5,3,6,15 and 30 μmol·L-1 for 24 h, or with Andro 30 μmol·L-1 for 4, 8, 12 and 24 h. MTT method was used to detect cell survival. In addition, A549 cells were divided into 2 groups: control group, in which cells were only stimulated with TNF-α 10 μg·L-1 for 0, 5, 15, and 30 min; Andro group, in which cells were pre-incubated with Andro 30 μmol·L-1 for 4 h before 30 minutes of stimulation of TNF-α 10 μg·L-1, to study the expression of NF-κB signaling proteins, including inhibitor of κB α (IκBα), phosphorylated IκBα, IκB kinase β(IKKβ) and phosphorylated IKKβ by Western blotting and NF-κB DNA binding activity by ELISA. RESULTS The concentration and duration of both Andro treatment were related to the survival rate of A549 cells that declined to (22.0±1.2)% after 24 h incubation with Andro 30 μmol·L-1. In addition, the treatment of Andro 1.5 μmol·L-1 for 24 h or Andro 30 μmol·L-1 for 4 h had no effect on the survival rate of A549 cells. Furthermore, Andro inhibited TNF-α-induced phosphorylation of IKKβ in A549 cells, reduced phosphorylation of IκBα, blocked the subsequent degradation of IκBα, and had no effect on the expression of IKKβ. Andro decreased the DNA binding activity of NF-κB p65 in the nucleus of A549 cells and the inhibitory rate was 32%. CONCLUSION Andro can inhibit the growth of A549 cells by blocking NF-κB signaling pathway.